Georges Lion

Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Journal: Diabetes & metabolism

Published: February 13, 2026

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 28, 2025

Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [18F]FDG PET/CT and 131I Posttreatment Scanning.

Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [18F]FDG PET/CT and 131I Posttreatment Scanning.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 25, 2024

When and how to evaluate adipose tissue in clinical practice? DEXA, impedancemetry.

When and how to evaluate adipose tissue in clinical practice? DEXA, impedancemetry.

Journal: Annales d'endocrinologie

Published: June 13, 2024

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 12, 2023

Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments.

Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments.

Journal: Presse medicale (Paris, France : 1983)

Published: September 21, 2022

Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma.

Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma.

Journal: Cancers

Published: July 04, 2022

Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy.

Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy.

Journal: AIDS (London, England)

Published: February 03, 2022

Metabolic and immunological phenotype of rare lipomatoses: Dercum's disease and Roch-Leri mesosomatic lipomatosis.

Metabolic and immunological phenotype of rare lipomatoses: Dercum's disease and Roch-Leri mesosomatic lipomatosis.

Journal: Orphanet journal of rare diseases

Published: March 21, 2021

Quantitative dual isotope 123iodine/99mTc-MIBI scintigraphy: A new approach to rule out malignancy in thyroid nodules.

Quantitative dual isotope 123iodine/99mTc-MIBI scintigraphy: A new approach to rule out malignancy in thyroid nodules.

Journal: Annales d'endocrinologie

Published: January 30, 2021

Prevalence and causes of elevated bone mass.

Prevalence and causes of elevated bone mass.

Journal: Bone

Published: March 26, 2020

Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients.

Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients.

Journal: Therapeutic advances in musculoskeletal disease

Published: February 25, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026